Cited by 96Pancreatic function and diabetesDiabetes and associated disordersPluripotent Stem Cells Research

Transplantation of Human Pancreatic Endoderm Cells Reverses Diabetes Post Transplantation in a Prevascularized Subcutaneous Site

Open access
Pepper, Andrew R., Pawlick, Rena, Bruni, Antonio, Wink, John, Rafiei, Yasmin, O’Gorman, Doug, Yan-Do, Richard, Gala-Lopez, Boris +3 more·2017·Stem Cell Reports

Abstract

Beta-cell replacement therapy is an effective means to restore glucose homeostasis in select humans with autoimmune diabetes. The scarcity of "healthy" human donor pancreata restricts the broader application of this effective curative therapy. "β-Like" cells derived from human embryonic stem cells (hESC), with the capacity to secrete insulin in a glucose-regulated manner, have been developed in vitro, with limitless capacity for expansion. Here we report long-term diabetes correction in mice transplanted with hESC-derived pancreatic endoderm cells (PECs) in a prevascularized subcutaneous site. This advancement mitigates chronic foreign-body response, utilizes a device- and growth factor-free approach, facilitates in vivo differentiation of PECs into glucose-responsive insulin-producing cells, and reliably restores glycemic control. Basal and stimulated human C-peptide secretion was detected throughout the study, which was abolished upon graft removal. Recipient mice demonstrated physiological clearance of glucose in response to metabolic challenge and safely retrieved grafts contained viable glucose regulatory cells.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.stemcr.2017.05.004

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Implanting a device into the subcutaneous space one month prior to cell transplantation pre-vascularized the graft site and avoided the several week lag time for vascularization.

    “For example, implanting a device into the subcutaneous space one month prior to cell transplantation pre-vascularized the graft site and avoided the several week lag time that it takes for vascularization to occur.145,151”

    From Developments in stem cell-derived islet replacement therapy for treating type 1 diabetes (2023) · cites this paper as [151]

    The Introduction describes temporarily implanting an angiocatheter to create a vascularized subcutaneous site before infusing the cell graft, and Experimental Procedures confirms that vascular catheters were used to prepare the site. Our copy does not specify implantation one month before transplantation or state that this avoided a several-week vascularization lag. (LLM, conf=0.84)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Pepper, A. R., Pawlick, R., Bruni, A., Wink, J., Rafiei, Y., O’Gorman, D., Yan-Do, R., Gala-Lopez, B., Kin, T., MacDonald, P. E., & Shapiro, A. M. J.
Affiliations
University of Alberta (CA)
Corresponding author
Shapiro, A.M. James
Venue
Stem Cell Reports
Publisher
Elsevier BV
Published
2017-06
Volume
8
Issue
6
Pages
1689-1700
ISSN
2213-6711 (ISSN-L)
OpenAlex
W2621794998
Cited by
96
References
34
Citations by year
2026: 5 · 2025: 5 · 2024: 16 · 2023: 10 · 2022: 10 · 2021: 13 · 2020: 10 · 2019: 11 · 2018: 14 · 2017: 2
FWCI
10.37
Type
journal article
Language
en
Open access
Locations
  • Stem Cell Reports (publishedVersion, cc-by-nc-nd)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Canadian Institutes of Health Research
  • Alberta Innovates - Health Solutions
  • University of Alberta
  • Canada Research Chairs
Topics
  • Health Sciences › Medicine › Surgery › Pancreatic function and diabetes
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
Keywords
human embryonic stem cells, beta cell replacement therapy, type 1 diabetes, glucose-dependent insulin secretion, C-peptide, graft survival, foreign body reaction, in vivo differentiation, glycemic control
MeSH terms
Human Embryonic Stem Cells, Animals, Blood Glucose, C-Peptide, Calcium, Cell Differentiation, Diabetes Mellitus, Experimental, Endoderm, Humans, Injections, Subcutaneous, Oxygen Consumption, Pancreas, Transplantation, Heterologous, Neovascularization, Physiologic, Insulin-Secreting Cells, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review